These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 2424090)
1. Future perspectives for biological response modifiers: a viewpoint. Mihich E Semin Oncol; 1986 Jun; 13(2):234-54. PubMed ID: 2424090 [No Abstract] [Full Text] [Related]
2. Biological response modifiers: their potential and limitations in cancer therapeutics. Mihich E Cancer Invest; 1985; 3(1):71-83. PubMed ID: 2578860 [No Abstract] [Full Text] [Related]
4. [BRM in the treatment of cancer]. Takaku F Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1597-602. PubMed ID: 2454612 [TBL] [Abstract][Full Text] [Related]
5. Biologicals and biological response modifiers: new approaches to cancer treatment. Oldham RK Cancer Invest; 1985; 3(1):53-70. PubMed ID: 3918773 [No Abstract] [Full Text] [Related]
6. Approaches to cancer therapy using biological response modifiers. MacEwen EG Vet Clin North Am Small Anim Pract; 1985 May; 15(3):667-88. PubMed ID: 2409659 [No Abstract] [Full Text] [Related]
7. Biologicals and biological response modifiers: fourth modality of cancer treatment. Oldham RK Cancer Treat Rep; 1984 Jan; 68(1):221-32. PubMed ID: 6198081 [TBL] [Abstract][Full Text] [Related]
8. Current status of melanoma treatment with interferon, cytokines and other biologic response modifiers in Japan. Ishihara K; Hayasaka K; Yamazaki N J Invest Dermatol; 1989 May; 92(5 Suppl):326S-328s. PubMed ID: 2469742 [TBL] [Abstract][Full Text] [Related]
9. Biological Response Modifiers Programme and cancer chemotherapy. Oldham RK Int J Tissue React; 1982; 4(3):173-88. PubMed ID: 6183193 [TBL] [Abstract][Full Text] [Related]
10. [Antineoplastic mechanism of immunotherapy in neoplastic cells]. Ogura T; Hosoe S Nihon Rinsho; 1986 Feb; 44(2):403-10. PubMed ID: 3517418 [No Abstract] [Full Text] [Related]
11. [Cytokines and monoclonal antibodies. Immunologic approaches to tumor therapy]. Pfreundschuh M Fortschr Med; 1986 Dec; 104(47-48):973-6. PubMed ID: 2434398 [No Abstract] [Full Text] [Related]
12. Lymphokines, monoclonal antibodies, and other biological response modifiers in the treatment of cancer. Oldham RK; Thurman GB; Talmadge JE; Stevenson HC; Foon KA Cancer; 1984 Dec; 54(11 Suppl):2795-806. PubMed ID: 6437660 [TBL] [Abstract][Full Text] [Related]